Abstract
Major histocompatibility complex class I (MHC I) molecules are glycoproteins that display peptide epitopes at the cell surface of nucleated cells for recognition by CD8+ T cells. Like other cell surface receptors, MHC class I molecules are continuously removed from the surface followed by intracellular degradation or recycling to the cell surface, in a process likely involving active quality control the mechanism of which remains unknown. The molecular players and pathways involved in internalization and recycling have previously been studied in model cell lines such as HeLa. However, dendritic cells (DCs), which rely on a specialized endocytic machinery that confers them the unique ability to “cross”-present antigens acquired by internalization, may use distinct MHC I recycling pathways and quality control mechanisms. By providing MHC I molecules cross-presenting antigens, these pathways may play an important role in one of the key functions of DCs, priming of T cell responses against pathogens and tumors. In this review, we will focus on endocytic recycling of MHC I molecules in various experimental conditions and cell types. We discuss the organization of the recycling pathway in model cell lines compared to DCs, highlighting the differences in the recycling rates and pathways of MHC I molecules between various cell types, and their putative functional consequences. Reviewing the literature, we find that conclusive evidence for significant recycling of MHC I molecules in primary DCs has yet to be demonstrated. We conclude that endocytic trafficking of MHC class I in DCs remains poorly understood and should be further studied because of its likely role in antigen cross-presentation.
Highlights
Major histocompatibility complex class I (MHC I) molecules present pathogen, tumor and self-antigens to CD8+ T cells through the endogenous or direct and the exogenous or cross-presentation [1, 2] pathways
Analysis of endocytic trafficking is complicated by the fact that MHC I molecules exist in various forms presumably sensed by mechanisms of quality control, and that may follow distinct intracellular trafficking pathways: trimers made of a heavy chain, beta-2 microglobulin (β2m), and high affinity peptides; trimers made of heavy chain, β2m, and low affinity peptides; dimers without any bound peptides; and free heavy chains (FHC)
One of the latter clathrin-independent endocytosis (CIE) pathways is named for the small GTPase Arf6 and has been widely described as the mechanism of endocytosis of MHC I molecules in model cell lines
Summary
MHC I molecules present pathogen, tumor and self-antigens to CD8+ T cells through the endogenous or direct and the exogenous or cross-presentation [1, 2] pathways. Analysis of endocytic trafficking is complicated by the fact that MHC I molecules exist in various forms presumably sensed by mechanisms of quality control, and that may follow distinct intracellular trafficking pathways: trimers made of a heavy chain, beta-2 microglobulin (β2m), and high affinity peptides; trimers made of heavy chain, β2m, and low affinity peptides; dimers without any bound peptides; and free heavy chains (FHC). Distinguishing complexes with high and low affinity peptides is important, since the affinity of the peptide-MHC interaction is the first determinant of the lifetime of class I molecules at the cell surface [8,9,10]. We anticipate that identification of such players will be required to fully understand endocytic trafficking and recycling of class I molecules, and conclusively answer the questions discussed below
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.